Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT00615394
Eligibility Criteria:
Inclusion Criteria:
* diagnosis made at more than two years and symptomatic at functional class III-IV by the New York Heart Association classification (NYHA) despite optimal pharmacologic therapy
* left ventricular ejection fraction (LVEF) less than 35%, by echocardiogram
* age below 60 years
* absence of neoplasm
* absence of hematologic disease or systemic disease
* no previous cardiac intervention
Exclusion Criteria:
* episodes of tachycardia or ventricular fibrillation
* severe or moderated mitral insufficiency
* any other valvulopathies
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00615394
Study Brief:
Protocol Section:
NCT00615394